One-year exacerbation frequency and treatment in the ECLIPSE study cohort

J. Vestbo, J. Hurst, H. Muellerova, N. Locantore, J. Wedzicha, A. Anzueto, ECLIPSE Investigators (SCO104960, NCT00292552) (Hvidovre, Denmark; London, United Kingdom; Research Triangle Park, San Antonio, United States Of America)

Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Session: COPD: exacerbation and clinical problems
Session type: Thematic Poster Session
Number: 3464
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vestbo, J. Hurst, H. Muellerova, N. Locantore, J. Wedzicha, A. Anzueto, ECLIPSE Investigators (SCO104960, NCT00292552) (Hvidovre, Denmark; London, United Kingdom; Research Triangle Park, San Antonio, United States Of America). One-year exacerbation frequency and treatment in the ECLIPSE study cohort. Eur Respir J 2009; 34: Suppl. 53, 3464

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021



A comparison of COPD patients with and without ACOS in the ECLIPSE study
Source: Eur Respir J 2016; 47:1559-1562
Year: 2016


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis.
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


Long-term prognosis in rehabilitated COPD patients. A 3-year controlled study and a 3-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 224s
Year: 2001

Prognosis of COPD according to exacerbation history: a population-based cohort study
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019


Predictors of non-response in a COPD exacerbation study
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020



Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study
Source: ERJ Open Res 2016
Year: 2016



Predictors of low risk of asthma exacerbation during pregnancyA prospective study of 1,283 pregnancies
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017

Efficacy of roflumilast in patients with a history of frequent exacerbations: Pooled data from pivotal 12-month studies
Source: Annual Congress 2010 - COPD: management
Year: 2010

Asthma exacerbations with long-term follow-up: a retrospective study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018



Heterogeneity in the clinical outcomes of COPD: lessons from the ECLIPSE study
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017


Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study
Source: Eur Respir J 2006; 28: Suppl. 50, 313s
Year: 2006

Four-year follow up of a COPD cohort, participation and mortality
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009